Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PKU EASY Liquid is a ready-to-drink, phenylalanine-free protein substitute designed for the dietary management of phenylketonuria (PKU) in patients aged 3 years and older. Developed by POA Pharma Scandinavia, it provides a concentrated source of essential and non-essential amino acids, vitamins, minerals, and trace elements, while excluding phenylalanine to prevent its toxic accumulation in the blood and brain. As a medical food (Food for Special Medical Purposes), it is used under medical supervision to ensure patients meet their nutritional requirements while adhering to a phenylalanine-restricted diet. The product is flavored to improve palatability and compliance in a population that requires lifelong dietary management.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PKU EASY Liquid.